THIS IS YOUR INVITATION
Our Mothers Got Screwed
Our mothers went through menopause at a time when no one talked about it, not their mothers, not their friends, and certainly not their doctors. They navigated one of the most significant physiological transitions of their lives with no language, no support, and no guidance. They got screwed.
Any woman fortunate enough to receive hormone therapy before the 2002 WHI report had it taken from her almost overnight. What followed was a climate of fear and restriction. Access disappeared. Understanding disappeared. And in the vacuum, prescriptions for non‑hormonal medications skyrocketed, SSRIs, synthetic birth control, anything but hormones.
These medications have their place, but we now know the truth:
SSRIs accelerate bone loss and reduce libido, compounding two of the most painful symptoms of menopause.
Synthetic birth control, while helpful for some, can flatten mood, disrupt gut health, and create nutritional deficiencies.
The situation was, quite literally, dire.
Any attempt to discuss hormone therapy with a clinician was met with alarm. The black box warning, now acknowledged as misleading, scared doctors away from offering the very treatment that could have protected women’s bones, brains, hearts, and quality of life.
Is it any wonder that loss of mobility, fractures, and cardiovascular disease became leading causes of death for this generation? These are systems kept healthy by hormones, the very thing they were denied.
Our mothers deserved better. And their story, her story, is the reason we refuse to repeat history.
The 2022 NAMS Breakthrough
Real progress arrived in 2022, when the North American Menopause Society finally updated its position statement. For the first time in decades, a major medical body said clearly what needed to be said:
“Hormone therapy remains the most effective treatment for vasomotor symptoms and genitourinary syndrome of menopause, and has been shown to prevent bone loss and fracture.”
Clear. Evidence‑based. Reasonable. A long‑overdue acknowledgment of the truth.
But then came the part that caused pause, and confusion, for postmenopausal women. The statement continued:
“For women younger than 60 or within 10 years of menopause onset, the benefit‑risk ratio is favorable… For women who initiate hormone therapy more than 10 years from menopause onset or who are older than 60, the benefit‑risk ratio appears less favorable…”
So, a woman is “safe” at 59 but suddenly “less safe” at 60? This is exactly where context and discernment matters. So, let's take a closer look.
In 2024, a landmark review of 10 million Medicare women on hormone therapy revealed something extraordinary:
Risk is not uniform across all hormone therapy.
Type, dose, and route matter.
Lower‑dose, transdermal, and vaginal estradiol have far more favorable safety profiles.
Older oral formulations do not behave like modern estradiol‑based therapies.
In response, NAMS published a follow‑up review and stated plainly:
“There is no general rule for stopping hormone therapy based on age alone.”
We celebrate the clarity, and the long-overdue access this statement restores.
They went further:
“For healthy women with persistent hot flashes, continuing hormone therapy beyond age 65 is a reasonable option with appropriate counseling… and the use of low‑dose, non‑oral routes becomes increasingly important as women age.”
At Ember, we agree, but we’d expand the frame. Hot flashes are not the only symptom that justifies continued therapy. Bone health, cognition, cardiovascular protection, sleep, mood, and quality of life matter too.
And the data is compelling: Women on estrogen alone saw:
19% reduction in mortality
16% reduction in breast cancer
11% reduction in cardiac events
This is not fringe. This is evidence‑based medicine that has been withheld from women for far too long.
Women older than 60 require shared-decision making with their provider to determine their unique risk to benefit profile. At Ember we view MHT as preventative care and support long-term use when clinically appropriate.
Mom, we want you healthy as long as possible.
This isn’t a comprehensive list of every symptom of menopause, but these are the ones that may affect her the most, and she likely gets the least support for. Let's change that.
Bone Health Matters
Osteoporosis-related fractures are one of the greatest threats to long-term health and independence in postmenopausal women. As estrogen declines, bone loss accelerates, increasing the risk of fractures, slower recovery, reduced mobility, and loss of confidence in everyday activities. MHT is recognized as an effective tool for osteoporosis prevention and can help preserve bone density before significant loss occurs. Protecting bone health today means protecting mobility, freedom, and quality of life for years to come.
Genitourinary Syndrome of Menopause (GSM)
GSM is one of the most common yet underdiagnosed conditions of menopause. As estrogen declines, the tissues of the vagina, urethra, and bladder lose critical hormonal support. Women may experience dryness, discomfort, painful intimacy, urinary urgency, burning, incontinence, and recurrent urinary tract infections.
The good news is that one of the most effective treatments is also one of the simplest. Low-dose vaginal estradiol, applied just twice weekly, can restore tissue health, improve comfort, reduce UTIs, and support long-term bladder function. Small intervention. Meaningful protection.
Muscle is Longevity
Muscle health is one of the strongest predictors of healthy aging. Strong muscles support strong bones, improve balance, reduce fall risk, and help maintain metabolic health. They also play a critical role in preserving independence and resilience as women age.
While MHT alone doesn't build muscle, testosterone therapy can support strength, recovery, energy, motivation, and lean muscle maintenance. Combined with movement and resistance training, it can help women stay active, capable, and physically confident throughout midlife and beyond.
Sexual Health is Health
Loss of libido, arousal, and sexual function is one of the most overlooked symptoms of menopause. Yet sexual wellbeing is closely connected to confidence, relationships, emotional health, and overall quality of life.
Both estrogen and testosterone have been shown to improve desire, arousal, orgasmic function, and sexual satisfaction in many women. At Ember, we believe sexual health deserves the same attention and respect as every other aspect of wellbeing. It is not a luxury, an afterthought, or something women simply have to accept losing—it is an important part of living fully.
WE GOT YOU
How We Approach Hormone Care at Ember
Personalized Hormone Care
At Ember, our approach to MHT is deeply personalized. There are many ways to use hormone therapy, different hormone types, different delivery methods, different dosing strategies, and what works beautifully for one woman may not work for another. We listen, adjust, and listen again until her plan feels right in her body and her life.
For postmenopausal women who are new to starting MHT, we utilize an advanced lab screening as a prudent and wise starting point to ensure mom is a great candidate.
Functional Health Lens
We approach every woman’s care through a functional‑health lens, because hormones never operate in a vacuum. They influence her glucose utilization, sleep, mood, metabolism, and overall wellbeing, and in turn, nutrition, movement, and supplements influence how her hormones behave. We weave this into a tailored program that supports her whole health, not just her hormone levels.
Ongoing Support
You’ll receive ongoing support because we already anticipate that adjustments will be needed along the way. Hormones aren’t linear, and neither is life, which is why responsive care matters. With our state‑of‑the‑art symptom tracker, you can communicate what you’re experiencing in real time, giving you the guidance you need, the words to describe what you are experiencing, and the care you deserve.
Why Women Choose EMBER
A membership that evolves with you. Your needs change over time, your care should too. Ember offers an industry-first membership structure that reduces as your care progresses. Once you are optimized, your membership rate will be too.
01
Built for Women. Built for This Chapter.
Women deserve care designed around their reality-not outdated systems. Every detail at Ember is built for the complexities of midlife.
02
Science Without the Noise.
Clear guidance. Thoughtful treatment. Evidence-based care explained in a way that feels human, empowering, and easy to understand.
03
A Membership That Evolves With You.
Your needs change over time. Your care should too. Ember adapts alongside you with ongoing support, optimization, and access.
04
More Than Care. A Community.
Built by women who are living this chapter themselves. A place where expertise, understanding, and belonging come together.
FAQ
Common postmenopause symptoms include vaginal dryness, low libido, brain fog, sleep changes, joint aches, thinning hair and skin, weight changes, and continued hot flashes for some women. Many women also notice changes in bone density and cardiovascular markers that don't cause obvious symptoms but matter for long-term health.
Symptoms shift over time. In your 50s, hot flashes and sleep issues are still common. By 60, vaginal dryness, joint stiffness, and bone density loss tend to be more prominent. By 65, cardiovascular and bone health become the bigger focus, even if day-to-day symptoms have eased. Every woman's timeline is different.
Focus on strength training and protein intake to protect muscle and bone, prioritize sleep, and stay on top of routine screenings like bone density scans, cholesterol panels, and mammograms. Ongoing hormone or nutrient support can also help depending on your symptoms and labs.
Declining estrogen reduces collagen and skin moisture, so a routine built around gentle cleansing, a strong moisturizer, daily SPF, and a retinoid or peptide-based product helps the most. Some women also see improvement in skin quality with hormone therapy, since estrogen directly affects collagen production. Topical estriol cream can be highly beneficial for facial skin.
Some women continue hormone therapy well into postmenopause, especially for ongoing symptom relief or bone protection, while others taper off. The decision depends on symptoms, bone density, and overall health, not just how many years have passed.
Common signs include persistent fatigue, weight gain around the midsection, low libido, mood changes, and thinning hair or skin. These can result from continued estrogen decline, low testosterone, or thyroid changes, so lab testing helps pinpoint the cause.